CBOA
RDY icon

Commonwealth Bank of Australia’s Dr. Reddy's Laboratories RDY Stock Holding History

Commonwealth Bank of Australia’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-8,022,030
Closed -$60.1M – 739
2019
Q2 		$60.1M Sell
8,022,030
-294,420
-4% -$2.31M 0.58% 34
2019
Q1 		$67.4M Sell
8,316,450
-276,815
-3% -$2.1M 0.64% 31
2018
Q4 		$64.8M Sell
8,593,265
-373,535
-4% -$2.63M 0.72% 30
2018
Q3 		$62M Buy
8,966,800
+165,830
+2% +$1.11M 0.6% 35
2018
Q2 		$56.7M Buy
8,800,970
+121,310
+1% +$765K 0.57% 32
2018
Q1 		$56.7M Sell
8,679,660
-13,975
-0.2% -$97.9K 0.61% 32
2017
Q4 		$65.3M Sell
8,693,635
-1,840,475
-17% -$13.3M 0.64% 35
2017
Q3 		$78.1M Sell
10,534,110
-6,728,555
-39% -$48.4M 0.76% 31
2017
Q2 		$145M Buy
17,262,665
+844,090
+5% +$6.86M 1.46% 16
2017
Q1 		$132M Sell
16,418,575
-2,786,660
-15% -$24.1M 1.44% 15
2016
Q4 		$174M Buy
19,205,235
+3,494,485
+22% +$32.5M 2.13% 12
2016
Q3 		$146M Sell
15,710,750
-145,880
-0.9% -$1.39M 1.73% 18
2016
Q2 		$162M Buy
15,856,630
+425,770
+3% +$3.9M 1.91% 16
2016
Q1 		$139M Buy
15,430,860
+715,275
+5% +$6.39M 1.7% 15
2015
Q4 		$136M Buy
14,715,585
+4,311,390
+41% +$47.2M 1.75% 10
2015
Q3 		$133M Sell
10,404,195
-1,708,710
-14% -$21.2M 1.7% 13
2015
Q2 		$134M Sell
12,112,905
-105,345
-0.9% -$1.16M 1.78% 13
2015
Q1 		$140M Buy
12,218,250
+54,475
+0.4% +$578K 1.88% 10
2014
Q4 		$123M Buy
12,163,775
+413,520
+4% +$4.35M 1.74% 13
2014
Q3 		$123M Hold
11,750,255
– – 1.6% 12
2014
Q2 		$101M Buy
11,750,255
+139,625
+1% +$1.17M 1.37% 15
2014
Q1 		$102M Buy
11,610,630
+73,415
+0.6% +$639K 0.65% 32
2013
Q4 		$94.7M Sell
11,537,215
-630,315
-5% -$4.99M 0.65% 27
2013
Q3 		$92M Sell
12,167,530
-791,430
-6% -$5.76M 0.67% 28
2013
Q2 		$98M Buy
+12,958,960
New +$94.6M 0.74% 25

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Commonwealth Bank of Australia's RDY Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Dr. Reddy's Laboratories (RDY) in Q3 2019, closing a stake of 8,022,030 shares — an estimated $60.1M sold.

Commonwealth Bank of Australia first reported a position in RDY in Q2 2013 and held it in 25 quarters. The position peaked at $174M in Q4 2016. 152 funds tracked by Wall St. Rank hold RDY as of Q3 2019.

  • Commonwealth Bank of Australia reported no remaining Dr. Reddy's Laboratories position as of Q3 2019 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 8,022,030 Dr. Reddy's Laboratories shares in Q3 2019, an estimated $60.1M.
  • Commonwealth Bank of Australia first reported a position in Dr. Reddy's Laboratories in Q2 2013 and held it in 25 quarters.
  • Commonwealth Bank of Australia's Dr. Reddy's Laboratories position peaked at $174M in Q4 2016.
  • 152 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.